Results

Total Results: 1,684 records

Showing results for "prostate cancer screening".
Users also searched for: psa

  1. www.talkingquality.ahrq.gov/health-literacy/professional-training/shared-decision/tool/resource-9.html
    September 01, 2020 - participants reported that providing patients with decision aids regarding their health treatment or screening … Colorectal cancer screening. Coronary revascularization for angina. … Prostate cancer screening. Prostatectomy for benign prostatic hypertrophy. … rigorously evaluates clinical research in order to assess the merits of preventive measures, including screening … Decision aids for people facing health treatment or screening decisions.
  2. ce.effectivehealthcare.ahrq.gov/health-literacy/professional-training/shared-decision/tool/resource-9.html
    September 01, 2020 - participants reported that providing patients with decision aids regarding their health treatment or screening … Colorectal cancer screening. Coronary revascularization for angina. … Prostate cancer screening. Prostatectomy for benign prostatic hypertrophy. … rigorously evaluates clinical research in order to assess the merits of preventive measures, including screening … Decision aids for people facing health treatment or screening decisions.
  3. www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/colorectal-cancer-screening3
    October 27, 2020 - of screening tests. … When performed alone, direct visualization tests allow for a much longer time between screenings compared … Colonoscopy allows the longest length between screenings (10 years), while flexible sigmoidoscopy and … CT colonography allow 5 years between screenings if performed alone. … results reflect accuracy after only a single application of the test rather than a program of repeated screenings
  4. effectivehealthcare-admin.ahrq.gov/products/methods-balancing-harms-benefits/research
    November 01, 2017 - Research Protocol Dec 20, 2024 Primary Hypofractionated Radiation Therapy for Localized ProstateCancer: A Systematic Review Systematic Review Aug 20, 2024 Treatment of Stage I-III … Anal Cancer Research Protocol Jul 22, 2024 Blood-based Tests for Multiple Cancer Screening
  5. www.uspreventiveservicestaskforce.org/home/getfilebytoken/3HxQuXnyqHpUKNqjB7hWBw
    September 01, 2005 - BRCA1 and BRCA2 mutations are also associated with in- creased risk for prostate cancer, and BRCA2 mutations … assigned according to the number of relatives, third-degree or closer, with breast, ovarian, colon, or prostatecancer, and the relationship to the proband, age at diagnosis, and type and number of cases of primary … Screening for ovarian cancer. … cancer screening (TAMCAS).
  6. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary14/lung-cancer-screening
    March 09, 2021 - Lung Screening Trial (NLST, N = 53,454) and Nederlands-Leuvens Longkanker Screenings Onderzoek (NELSON … Cancer Screening Intervention Trial (LUSI), and the Nederlands- Leuvens Longkanker Screenings Onderzoek … Results of the two incidence screenings in the National Lung Screening Trial. … Longkanker Screenings Onderzoek; and NLST, National Lung Screening Trial. … Screenings Onderzoek; NLST, National Lung Screening Trial; NR, not reported; RCT, randomized clinical
  7. www.cahps.ahrq.gov/research/findings/evidence-based-reports/search.html?page=6
    November 01, 2020 - Reports Affiliation: Mayo Clinic Report Status: Final Therapies for Clinically Localized ProstateCancer Date: September 2020 Report Type: Comparative Effectiveness Reviews Affiliation: Minnesota … Assessment Program Reports Affiliation: Johns Hopkins University Report Status: Final Screening … Comparative Effectiveness Reviews Affiliation: Duke University Report Status: Final Screening
  8. www.innovations.ahrq.gov/research/findings/evidence-based-reports/search.html?page=6
    November 01, 2020 - Reports Affiliation: Mayo Clinic Report Status: Final Therapies for Clinically Localized ProstateCancer Date: September 2020 Report Type: Comparative Effectiveness Reviews Affiliation: Minnesota … Assessment Program Reports Affiliation: Johns Hopkins University Report Status: Final Screening … Comparative Effectiveness Reviews Affiliation: Duke University Report Status: Final Screening
  9. www.monahrq.ahrq.gov/research/findings/evidence-based-reports/search.html?page=6
    November 01, 2020 - Reports Affiliation: Mayo Clinic Report Status: Final Therapies for Clinically Localized ProstateCancer Date: September 2020 Report Type: Comparative Effectiveness Reviews Affiliation: Minnesota … Assessment Program Reports Affiliation: Johns Hopkins University Report Status: Final Screening … Comparative Effectiveness Reviews Affiliation: Duke University Report Status: Final Screening
  10. www.healthcare411.ahrq.gov/research/findings/evidence-based-reports/search.html?page=6
    November 01, 2020 - Reports Affiliation: Mayo Clinic Report Status: Final Therapies for Clinically Localized ProstateCancer Date: September 2020 Report Type: Comparative Effectiveness Reviews Affiliation: Minnesota … Assessment Program Reports Affiliation: Johns Hopkins University Report Status: Final Screening … Comparative Effectiveness Reviews Affiliation: Duke University Report Status: Final Screening
  11. www.qualitymeasures.ahrq.gov/research/findings/evidence-based-reports/search.html?page=6
    November 01, 2020 - Reports Affiliation: Mayo Clinic Report Status: Final Therapies for Clinically Localized ProstateCancer Date: September 2020 Report Type: Comparative Effectiveness Reviews Affiliation: Minnesota … Assessment Program Reports Affiliation: Johns Hopkins University Report Status: Final Screening … Comparative Effectiveness Reviews Affiliation: Duke University Report Status: Final Screening
  12. www.talkingquality.ahrq.gov/research/findings/evidence-based-reports/search.html?page=6
    November 01, 2020 - Reports Affiliation: Mayo Clinic Report Status: Final Therapies for Clinically Localized ProstateCancer Date: September 2020 Report Type: Comparative Effectiveness Reviews Affiliation: Minnesota … Assessment Program Reports Affiliation: Johns Hopkins University Report Status: Final Screening … Comparative Effectiveness Reviews Affiliation: Duke University Report Status: Final Screening
  13. www.cpsi.ahrq.gov/research/findings/evidence-based-reports/search.html?page=6
    November 01, 2020 - Reports Affiliation: Mayo Clinic Report Status: Final Therapies for Clinically Localized ProstateCancer Date: September 2020 Report Type: Comparative Effectiveness Reviews Affiliation: Minnesota … Assessment Program Reports Affiliation: Johns Hopkins University Report Status: Final Screening … Comparative Effectiveness Reviews Affiliation: Duke University Report Status: Final Screening
  14. teamstepps.ahrq.gov/research/findings/evidence-based-reports/search.html?page=6
    November 01, 2020 - Reports Affiliation: Mayo Clinic Report Status: Final Therapies for Clinically Localized ProstateCancer Date: September 2020 Report Type: Comparative Effectiveness Reviews Affiliation: Minnesota … Assessment Program Reports Affiliation: Johns Hopkins University Report Status: Final Screening … Comparative Effectiveness Reviews Affiliation: Duke University Report Status: Final Screening
  15. patientregistry.ahrq.gov/research/findings/evidence-based-reports/search.html?page=6
    November 01, 2020 - Reports Affiliation: Mayo Clinic Report Status: Final Therapies for Clinically Localized ProstateCancer Date: September 2020 Report Type: Comparative Effectiveness Reviews Affiliation: Minnesota … Assessment Program Reports Affiliation: Johns Hopkins University Report Status: Final Screening … Comparative Effectiveness Reviews Affiliation: Duke University Report Status: Final Screening
  16. ahrqpubs.ahrq.gov/research/findings/evidence-based-reports/search.html?page=6
    November 01, 2020 - Reports Affiliation: Mayo Clinic Report Status: Final Therapies for Clinically Localized ProstateCancer Date: September 2020 Report Type: Comparative Effectiveness Reviews Affiliation: Minnesota … Assessment Program Reports Affiliation: Johns Hopkins University Report Status: Final Screening … Comparative Effectiveness Reviews Affiliation: Duke University Report Status: Final Screening
  17. healthcare411.ahrq.gov/research/findings/evidence-based-reports/search.html?page=6
    November 01, 2020 - Reports Affiliation: Mayo Clinic Report Status: Final Therapies for Clinically Localized ProstateCancer Date: September 2020 Report Type: Comparative Effectiveness Reviews Affiliation: Minnesota … Assessment Program Reports Affiliation: Johns Hopkins University Report Status: Final Screening … Comparative Effectiveness Reviews Affiliation: Duke University Report Status: Final Screening
  18. cahps.ahrq.gov/research/findings/evidence-based-reports/search.html?page=6
    November 01, 2020 - Reports Affiliation: Mayo Clinic Report Status: Final Therapies for Clinically Localized ProstateCancer Date: September 2020 Report Type: Comparative Effectiveness Reviews Affiliation: Minnesota … Assessment Program Reports Affiliation: Johns Hopkins University Report Status: Final Screening … Comparative Effectiveness Reviews Affiliation: Duke University Report Status: Final Screening
  19. monahrq.ahrq.gov/research/findings/evidence-based-reports/search.html?page=6
    November 01, 2020 - Reports Affiliation: Mayo Clinic Report Status: Final Therapies for Clinically Localized ProstateCancer Date: September 2020 Report Type: Comparative Effectiveness Reviews Affiliation: Minnesota … Assessment Program Reports Affiliation: Johns Hopkins University Report Status: Final Screening … Comparative Effectiveness Reviews Affiliation: Duke University Report Status: Final Screening
  20. effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/1-what-is-the-etiology-of-acute-and-chronic-urinary-retention-in-adults-2-how-do-we-define-urinary-retention-base-case-including-those-with-known-neurologic-problems-aka-what-is-considered-abnormal-pvr-3-what-is-the-natural-
    November 01, 2017 - Advanced Prostate Cancer in men which has invaded the urethra or bladder neck is another obstructive … availability of non invasive bladder scanners and ultrasound technology, many clinicians have included screening